News NewLimit raises $435m for liver trials, and other financings Longevity biotech NewLimit's $435m Series C heads this week's round-up of biotech venture capital financings.
News Spero snaps up Innovent immunology drug in strategic pivot Spero has licensed rights to an anti-CD40L antibody developed by China's Innovent, in a $1.1bn deal that signals a shift away from antimicrobial R&D.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
